November 13, 2026
The Fifth Circuit on Friday upheld the dismissal of a False Claims Act suit brought by a former Ventavia Research Group LLC director who briefly oversaw clinical trials for Pfizer Inc.'s COVID-19 vaccine, after the federal government argued her challenge to the scientific integrity of the trials conflicted with public health policy.